Related Experiment Video
Updated: Sep 13, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Cerebrovascular Thrombosis in Pediatric Ulcerative Colitis: A Case Report
Naire Sansotta1, Fabiana Di Stasio2, Angela Amoroso1
1Pediatric Hepatology, Gastroenterology and Transplantation, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy.
Insights
Cerebral thrombosis (CT) is a serious complication in pediatric inflammatory bowel disease (IBD). Early diagnosis and treatment with low-molecular-weight heparin (LMWH) are vital for managing this condition and improving patient outcomes.
Area of Science:
- Pediatric Gastroenterology
- Pediatric Neurology
- Thrombosis Research
Background:
- Inflammatory bowel disease (IBD) is associated with an increased risk of venous thromboembolism (VTE).
- Cerebral thrombosis (CT) is the most frequent VTE manifestation in pediatric IBD patients.
- Current data on CT in pediatric IBD are limited.
Observation:
- A 12-year-old boy with ulcerative colitis experienced a severe headache and vomiting during an IBD flare.
- Brain MRI confirmed cerebral venous thrombosis.
- The patient was treated with low-molecular-weight heparin (LMWH).
Findings:
- Follow-up imaging showed partial resolution of the cerebral venous thrombosis after four months of LMWH therapy.
- The patient completed 12 months of anticoagulation.
- No focal neurological deficits were observed during the presentation.
Implications:
- Cerebral venous thrombosis should be considered in pediatric IBD patients presenting with persistent headaches.
- Prompt diagnosis and anticoagulation are crucial for managing CT in this population.
- Further research is needed to understand the long-term outcomes and optimal management strategies for CT in pediatric IBD.
Abstract:
Background and Clinical Significance: Venous thromboembolism (VTE) is a severe extra-intestinal manifestation that can complicate the course of inflammatory bowel disease (IBD). Among pediatric patients, cerebral thrombosis (CT) is the most common form of VTE associated with IBD. Magnetic resonance imaging (MRI) remains the gold standard for diagnosing cerebral venous thrombosis, allowing visualization of flow absence and intraluminal thrombus. Prompt initiation of treatment with low-molecular-weight heparin (LMWH) is crucial to prevent complications. Follow-up imaging is essential to evaluate venous recanalization and guide therapy duration. However, data on cerebral thrombosis in pediatric patient with IBD remain scarce. Case Presentation: We report the case of a 12-year-old boy with a known history of ulcerative colitis who presented to the emergency room (ER) with a two-day history of headache and vomiting. One month prior to the ER visit, he experienced an IBD flare confirmed through clinical, biochemical, and endoscopic evaluation and was subsequently started on oral corticosteroids. Neurological examination was unremarkable; however, given the persistence of severe headache, a brain MRI was performed, leading to a diagnosis of cerebral venous thrombosis. Anticoagulation therapy with LMWH was initiated immediately. Follow-up imaging with contrast-enhanced MR venography four months later revealed partial resolution of the thrombosis. The patient continued long-term anticoagulation therapy for a total duration of 12 months. Conclusions: Cerebral venous thrombosis is a serious complication of IBD, particularly in pediatric patients. Clinicians should consider this diagnosis in any child with IBD presenting with persistent headache, even in the absence of focal neurological signs. Early diagnosis and prompt anticoagulation therapy are key to improving outcomes in these patients.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

